VENDITTI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 114
AS - Asia 78
EU - Europa 62
SA - Sud America 34
AF - Africa 2
Totale 290
Nazione #
US - Stati Uniti d'America 112
SG - Singapore 39
BR - Brasile 32
HK - Hong Kong 14
RU - Federazione Russa 13
SE - Svezia 12
CN - Cina 11
DE - Germania 10
IT - Italia 8
FI - Finlandia 4
IN - India 4
VN - Vietnam 4
AT - Austria 3
FR - Francia 3
GB - Regno Unito 3
PL - Polonia 3
CA - Canada 2
CO - Colombia 2
IE - Irlanda 2
AE - Emirati Arabi Uniti 1
DJ - Gibuti 1
ES - Italia 1
KZ - Kazakistan 1
MY - Malesia 1
PK - Pakistan 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 290
Città #
Singapore 24
Ashburn 14
Hong Kong 14
Fairfield 11
Nyköping 11
Falkenstein 7
Bari 6
Beijing 6
Lawrence 5
Roxbury 5
Cambridge 4
Chandler 4
Helsinki 4
New York 4
Buffalo 3
Dallas 3
Des Moines 3
Los Angeles 3
Ann Arbor 2
Atlanta 2
Chicago 2
Dublin 2
Ho Chi Minh City 2
Houston 2
Medellín 2
Munich 2
Rio de Janeiro 2
San Diego 2
São Paulo 2
Wilmington 2
Woodbridge 2
Alegrete 1
Almenara 1
Amritsar 1
Ankara 1
Araraquara 1
Atibaia 1
Bakersfield 1
Belfast 1
Belo Horizonte 1
Bologna 1
Brasília 1
Brooklyn 1
Campinas 1
Campo Grande 1
Carapicuíba 1
Chennai 1
Curitiba 1
Cândido Godói 1
Djibouti 1
Fernandópolis 1
Formiga 1
Guangzhou 1
Guarulhos 1
Inglewood 1
Ipaussu 1
Itaituba 1
Joinville 1
João Monlevade 1
Karachi 1
Kuala Lumpur 1
London 1
Maceió 1
Manchester 1
Marseille 1
Matão 1
Mongaguá 1
Mumbai 1
Ninh Bình 1
Novosibirsk 1
Olinda 1
Ottawa 1
Paris 1
Porto Alegre 1
Pune 1
Quatá 1
Queens 1
Sacramento 1
Santa Clara 1
Santa Helena 1
Semey 1
Serra Talhada 1
Shanghai 1
Sharjah 1
Stockholm 1
Tashkent 1
Thái Nguyên 1
Topeka 1
Três Lagoas 1
Venda Nova do Imigrante 1
Verdellino 1
Vienna 1
Winnipeg 1
Totale 219
Nome #
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 71
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 60
Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+) 49
P116 Azacitidine for the treatment of lower risk myelodysplastic syndromes: final results from an Italian named patient program 43
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia 40
Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy 37
Totale 300
Categoria #
all - tutte 2.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202247 3 26 0 0 0 1 5 2 0 1 4 5
2022/202327 5 5 1 0 0 5 1 2 6 0 2 0
2023/202419 3 6 0 1 3 5 0 0 0 0 0 1
2024/2025115 4 0 7 0 2 20 14 12 6 8 13 29
2025/202692 32 9 8 13 22 8 0 0 0 0 0 0
Totale 300